$ACOG
Alpha Cognition Inc. Common Stock
XNAS•Health Care•Biological Products, (No Diagnostic Substances)
$8.31
▲+0.00%+$0.000
Subscriptions are live. Early access $24.99/mo, or start with 5 free premium days.
Plans & pricingDonateAlpha Cognition Inc. Common Stock
XNAS•Health Care•Biological Products, (No Diagnostic Substances)
Why is ACOG up today? It is at $8.31 (+0.00%), and our scanner flagged it 19 times on unusual volume this month. See the catalyst behind the move, real-time alerts the moment ACOG spikes, and full due diligence on ACOG — key stats, earnings, dilution and insider activity. Free.
Our scanner flagged $ACOG 19 times in the last 30 days. Create a free account to track $ACOG, build a watchlist, and get instant unusual-volume alerts, with a full day of premium now and 5 more when you verify your email, no card needed.
No card · 5 premium days · join 800+ traders
The top plays and unusual-volume catches our scanner flags, emailed to you. No account needed.
No spam. Unsubscribe anytime. Not investment advice.
Here is the latest on ACOG from our scanner (live price and day move above). We have not detected an unusual-volume catalyst for ACOG today, so it is trading in line with its recent range. The moment our scanner flags unusual activity, the reason will appear here.
Likely catalystAlpha Cognition Inc.: Q2 FY2026 results, three months to Jun 30, 2025, from an SEC filing. Read it →Latest filing4Insider trade (Form 4)Oct 20, 2026 · 3 days agoSources: float & market cap via Polygon · short interest via FINRA · borrow & shortability via Alpaca · SSR from Reg SHO 201 · filings & dilution via SEC EDGAR · analysts via Nasdaq.
Auto-generated from public data for research and education. Not investment advice.
| Insider | Action | Shares | % of position | Owns after | Value | Date |
|---|---|---|---|---|---|---|
Opaleye Management Inc. Beneficial Owner (10%) | Bought (open market) | +14K 0.07% of company | added 0.4% | 3.36M | $118K at $8.23 | Oct 16, 26 |
Opaleye Management Inc. Beneficial Owner (10%) | Bought (open market) | +23K 0.1% of company | added 0.7% | 3.25M | $191K at $8.43 | Oct 15, 26 |
Opaleye Management Inc. Beneficial Owner (10%) | Bought (open market) | +19K 0.09% of company | added 0.6% | 3.32M | $166K at $8.69 | Oct 1, 26 |
Opaleye Management Inc. Beneficial Owner (10%) | Bought (open market) | +13K 0.06% of company | added 0.4% | 3.30M | $114K at $8.47 | Sep 25, 26 |
Opaleye Management Inc. Beneficial Owner (10%) | Bought (open market) | +18K 0.08% of company | added 0.6% | 3.19M | $157K at $8.57 | Sep 24, 26 |
Opaleye Management Inc. Beneficial Owner (10%) | Bought (open market) | +80K 0.4% of company | added 2.5% | 3.27M | $673K at $8.40 | Sep 16, 26 |
Opaleye Management Inc. Beneficial Owner (10%) | Bought (open market) | +3K 0.02% of company | added 0.1% | 3.09M | $29K at $8.54 | Sep 15, 26 |
Opaleye Management Inc. Beneficial Owner (10%) | Bought (open market) | +40K 0.2% of company | added 1.3% | 3.09M | $351K at $8.70 | Sep 14, 26 |
Wills Robert James Director | Bought (open market) | +10K 0.05% of company | added 45% | 32K | $96K at $9.62 | Aug 21, 26 |
Opaleye Management Inc. Beneficial Owner (10%) | Bought (open market) | +50K 0.2% of company | added 1.6% | 3.15M | $400K at $8.00 | Aug 3, 26 |
Opaleye Management Inc. Beneficial Owner (10%) | Bought (open market) | +3K 0.01% of company | added <0.1% | 3.00M | $23K at $7.92 | Jul 31, 26 |
Opaleye Management Inc. Beneficial Owner (10%) | Bought (open market) | +130 | added <0.1% | 3.10M | $1K at $7.90 | Jul 24, 26 |
Recent Form-4 filings via Nasdaq. Open-market buys are the signal worth watching. Grants and automatic (10b5-1) sells are routine. “% of position” is the share of that insider’s own holding the trade moved. Not investment advice.
Blend of news sentiment, today’s move, and community votes. Not investment advice.
News, unusual-volume alerts, AI-trader trades and community chatter - the whole story, newest first.
The tickers our scanner is lighting up most over the last 48 hours.
Comparable names in biological products, (no diagnostic substances), closest in size first.
Here is the latest on ACOG from our scanner (live price and day move above). We have not detected an unusual-volume catalyst for ACOG today, so it is trading in line with its recent range. The moment our scanner flags unusual activity, the reason will appear here.
ACOG last traded at $8.31, up 0.00% on the day. The price and chart above update live during market hours (4 AM to 8 PM ET).
Alpha Cognition Inc. Common Stock (ACOG) is next expected to report earnings on Thursday, November 12, 2026, about 20 days away. Earnings reports often cause large overnight gaps, so many traders manage risk around the date. The date can shift until the company officially confirms it.
The ACOG Live Alerts panel on this page streams real-time unusual volume (RVOL), momentum, halt and 200-EMA alerts from our scanner the moment they fire. Our scanner has flagged ACOG 19 times in the last 30 days.
ACOG (Alpha Cognition Inc. Common Stock) trades on XNAS, with a market cap of about $181M in the Biological Products, (No Diagnostic Substances) sector.
That depends on your strategy and risk. Day traders look for volume, volatility and a clear trend. Use the live chart, RVOL alerts and 200-EMA context on this page to judge ACOG for yourself. This is not investment advice.
Live data from TheDesperateTrader scanner. Not investment advice.
$ACOG discussion
Sign in to ask a question or join the discussion.